1. THE CHEMISTRY OF GOLD 1.1. properties of the element 1.2. colloidal gold 1.3 . physical methods for the study of gold compounds 1.4 . oxidation states 1.5 4 POTENTIAL GOLD ANTITUMOUR DRUGS 1 . THE CHEMISTRY OF GOLD For many centuries gold has occupied a special place in medicine as a potential "cure-all" for diseases. As early as 2500 BC gold was used in Chinese and Arabic medicine. In the 8th century it was advocated as an elixir of youth, and in the Middle Ages gold mixtures were prescribed for a range of conditions. It was not until 1890 that Koch discovered that the gold(I) dicyanide ion had antitubercular activity, although this was subsequently shown to have little benefit for the treatment of the disease. 2 During the search for non-toxic gold(I) complexes with antitubercular activity, gold(I) thiolate complexes were synthesized. These were used extensively during "the golden decade" from [1925] [1926] [1927] [1928] [1929] [1930] [1931] [1932] [1933] [1934] [1935] for the treatment of tuberculosis. 1, 3 In 1929, Forestier found that gold was effective for the treatment of rheumatoid arthritis, 4 but it was not until 1960 that controlled clinical trials were able to prove the efficacy of gold therapy. Today for the treatment of rheumatoid arthritis, injectable gold(I)
thiolates have been supplemented in the clinic by the orally-active gold(I) phosphine complex (aumnofin). Aumnofin is also being used in the clinic for psoriatic arthritis, juvenile rheumatoid arthritis and is on clinical trial as an antiasthmatic.
There is potential for more extensive use of gold in therapy based on the rational design of new gold compounds. The interest in this area is displayed in the large number of reviews on various aspects, such as those by Shaw (1979) , 5 Brown and Smith (1980) , 6 Berners-Price and Sadler (1986), 7 Champion et al. (1990) , 8 Dash and Schmidbauer (1990), 9 Smith and Reglinski (1991), 10 
Colloidal gold
Under favourable conditions, solutions of Au(lll) can be reduced to colloidal gold. These may be red, blue or violet in colour depending on the method of preparation, mean particle size, and shape.
"Purple of Cassius", generated in this manner has been used as a colouring in ceramics for several centuries. Indeed the "potable gold" used in the past as a "cure-all" was obtained by reduction of a solution of gold in aqua regia and diluted with essential oils such as oil of rosemary. The surfaces of colloidal gold particles carry a negative charge and so can adsorb strongly to proteins. This has led to the use of colloidal gold as a cytochemical marker in electron microscopy for protein binding studies. 14 For example, colloidal gold labelled with antibodies can be used to probe antigenic sites on cell surfaces. Imaging of the liver can be carried out using mdiolabelled 198Au administered by injection.
Macrophages also take up gold particles by phagocytosis. Recently, ultrasound has been used to give small (<10 nm) particles, 15 and reduction with [P(CH2OH)4]CI gives even smaller particles (1.5 rim). 16 
Physical methods for the study of gold compounds
There are few methods for the direct probing gold in gold complexes. These include 197Au M6ssbauer 17 and X-ray absorption spectroscopy. 18 197Au (100% abundance) NMR has not been useful for examining gold complexes since the nucleus is quadrupolar (1=3/2) with a large quadrupole moment and low gyromagnetic ratio. Only in the most symmetrical compounds would the 197Au NMR signal be expected to be sharp enough to observe, and then only at high concentrations. No useful chemical studies have been done, and nuclear quadrupole resonance has also not found wide applications for gold. Single crystal X-ray diffraction give useful structural data if suitable crystals can be obtained, indeed gold derivatives are often used to solve the phase problem in protein crystallography. Extended X-ray absorption fine structure (EXAFS; e.g. LII edge) and wide angle X-ray scattering (WAXS) have been used to study the gold coordination sphere in a number of complexes. Electron paramagnetic resonance (EPR) has been used to study several Au(ll) compounds 13 70 Indeed it has been shown that treatment of albumin with (Et3P)2AuCI results in the formation of AIb-Cys-S-AuPEt3 and free Et3P which is in turn oxidised by disulfide bridges in albumin. The free thiols formed may then bind more gold drug. This results in a family of gold-albumin complexes with variation in the position of gold binding determined by which of the disulfide bridges is reduced. 71 EtP=O This is an illustration of the trans effect, resulting in labilization of the phosphine and although the first step is reversible, the second step is irreversible and results in gradual loss of the phosphine.
Interestingly the effect is observed only for tetraacetylthioglucose and not for thioglucose or glutathione. Figure 7 .
Chlom(pyridine)gold(I) and trichloro(pyridine)gold(lll) both appear to react with a number of different conformations of pBR322 DNA to produce inter-strand cross-links and single-strand breaks as does Et3PAuCI3. On the other hand the Au(I) complex, Et3PAuCI binds without the formation of cross-links. The amount of cross-linking can be reduced by the addition of thiols such as 2- mercaptoethanol, again illustrating the strength of Au(I)-P and Au(I)-S bonds. 94, 114 Gold ( (Table 3) . 122 The corresponding Au(lll) complex, [CI3Au(#-dppe)AuCI3], also shows activity. 123 The structures of the bridged linear Au(I) complexes are assumed to be the same as [CIAu(l-dppe)AuCI], which has linear 2-coordinate Au(I). 124 The Chemistry of Gold Dntg, Et3PAu(PPh3)CI 13 52 6 (CH3)3PAuCI 16 34 6 (allyl)3PAuCI 5 25 5 Et2(HOBu) PAuCI compared to diphosphines is probably a reflection of the increased kinetic lability and lower thermodynamic stability of Au-As bonds compared to Au-P bonds, and hence the ligand is more easily displaced and detoxified by oxidation. 132 In contrast to R3PAuX complexes in the auranofin series, the antitumour activity of the bridged digold complexes increases when X is a good leaving group (with R3PAuX complexes good leaving groups result in binding to serum proteins such as albumin). This is probably related to the conversion of the linear bridged complexes to the kinetically stable tetrahedral complexes. The major drawback to the clinical use of tetrahedral complexes such as [Au(dppe)2]/ is their ability to uncouple mitochondrial oxidative phosphorylation by increasing the permeability of the mitochondrial membrane to cations, with collapse of the mitochondrial membrane potential. 133 In preclinical trials, [Au(dppe)2]+ exhibited cardiac, hepatic and vascular toxicity. 134, 135 
